DavidH.MunnMD
Pediatric Hematology & Oncology • Augusta, GAProfessor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University
Are you Dr. Munn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-3626Fax+1 706-721-2643- Is this information wrong?
Summary
- Dr. David Munn, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia. He is a Professor at Medical College of Georgia at Georgia Health Sciences University.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1987 - 1990
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1984 - 1987
Medical College of Georgia at Augusta UniversityClass of 1984
Certifications & Licensure
GA State Medical License 1990 - 2015
Publications & Presentations
PubMed
- 2 citationsEnniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer.Nada H Eisa, Vincent M Crowley, Asif Elahi, Vamsi Krishna Kommalapati, Michael A Serwetnyk, Taoufik Llbiyi, Sumin Lu, Kashish Kainth, Yasmeen Jilani, Daniela Marasco, ...> ;Iscience. 2023 Dec 15
- 2 citationsIndoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.Theodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, Dolly Aguilera, Ahmad Al-Basheer, Manish Bajaj, Pratiti Bandopadhayay, Zuzana Berrong, Eric Bouffet, Robert C ...> ;Neuro-Oncology. 2024 Feb 2
- 19 citationsTumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment.John D Klement, Priscilla S Redd, Chunwan Lu, Alyssa D Merting, Dakota B Poschel, Dafeng Yang, Natasha M Savage, Gang Zhou, David H Munn, Padraic G Fallon, Kebin Liu> ;Cancer Cell. 2023 Mar 13
- Join now to see all
Press Mentions
- Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
- Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023
- Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of PsoriasisFebruary 28th, 2022
- Join now to see all
Grant Support
- Ido-Mediated Immune Regulation In Established TumorsNational Cancer Institute2010–2012
- Role Of IDO MalignancyNational Cancer Institute2010–2011
- Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2010–2011
- Role Of IDO MalignancyNational Cancer Institute2007–2009
- Ido-Expressing Plasmacytoid Dendritic Cells And TumorsNational Cancer Institute2005–2009
- Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2003–2009
- Role Of IDO In MalignancyNational Cancer Institute2003–2006
- Macrophage Mediated Immunoregulation VIA TryptophanNational Heart, Lung, And Blood Institute1999–2002
- Inhibition Of T Cells By Tryptophan DegradationNational Institute Of Allergy And Infectious Diseases1998–1999
- Regulation Of Macrophage ApoptosisNational Heart, Lung, And Blood Institute1995–1997
